SG

Srihari Galla

Active Director Director DIN 09654802
DIN 09654802 First appointment Jun 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2022
Shareholding value Locked Premium profile

About Srihari Galla

Srihari Galla has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Apicules Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09654802
Primary Designation Director
First Appointment 28 Jun 2022
Oldest Company Age 4 yrs

Current companies

Company Designation Appointment Founded Status
Director 28 Jun 2022 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apicules Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srihari Galla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srihari Galla

Srihari Galla has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Apicules Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Srihari Galla is associated with 1 company as Director.

Srihari Galla has expertise in General Business.

Srihari Galla has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available